Patients
Treated
Total Number of Treatments
Serious Adverse Events
Pain freedom at 2 hours¹
Pain relief at 2 hours¹
Pain freedom at 2 hours with sustained pain freedom at 24 hours³
Tepper SJ, Sharon R. Migraine Treatment with e-COTNS – a randomized controlled trial. 2022
Sharon, R. Non-invasive e-COTNS Established Efficacy, Safety and Tolerability. American Neurological Association. 2021.
Relivion is an FDA cleared, innovative disease management system that integrates a wearable device, a patient-focused app, and a physician database interface, all enhanced by cloud-based AI. This platform represents the cutting edge in neuromodulation technology for migraine treatment.
Relivion non-invasive technology is designed to achieve complete stimulation of the TCC and modulate brain activity to alleviate the burden of migraine and associated pain symptoms.
Relivion is the first and only neuromodulation therapy to simultaneously stimulate specific nerve branches, offering:
Non-invasive,
drug-free therapy.
Adaptive stimulation
for tailored treatment.
Multi-focal stimulation for
precise and effective relief.
The PMI offers real-time access to patient data, enabling:
Comprehensive training in neuromodulation and device application.
Account setup for PMI to manage patient treatment effectively.
Access to prescription forms for offering Relivion MG treatments.
Neurolief Inc.
10211 W. Sample Rd. #217
Coral Springs, FL 33065
1-888-4RELIVION (888-473-5484)
www.relivion.com
Advanced Medical DME, LLC
10211 W. Sample Rd. #217
Coral Springs, FL 33065
Phone: 754-812-1935
Fax: 954-775-0151
support@relivion-medical.com
Neurolief Ltd.
12 Giborei Israel
Netanya, Israel 4250412
+972-9-3730288
www.relivion.com